Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR4 | Q13639 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | SMYD2 | Q9NRG4 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18360395 | 0.99 | HTR4 (0.48) | HTR4MAPTSMYD2TP53LMNA | |
| SCHEMBL18360465 | 0.88 | SMYD2 (0.44) | HTR4SMYD2LMNAACHEBACE1 | |
| SCHEMBL18360536 | 0.86 | SMYD2 (0.44) | HTR4SMYD2LMNASMN1; SMN2ACHE | |
| SCHEMBL18360540 | 0.83 | NAMPT (0.51) | MAPTSMYD2LMNASMN1; SMN2 | |
| SCHEMBL18360415 | 0.82 | CA12 (0.51) | MAPTSMYD2SMN1; SMN2 | |
| SCHEMBL18360513 | 0.77 | CA1 (0.41) | — | |
| SCHEMBL18360475 | 0.75 | CA1 (0.56) | MAPTLMNAKDM4E | |
| SCHEMBL18360514 | 0.74 | CA1 (0.39) | — | |
| SCHEMBL18360398 | 0.73 | NPC1 (0.52) | MAPTTP53LMNASMN1; SMN2 | |
| SCHEMBL18360397 | 0.73 | CA1 (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170000133-A1 | BENZOXABOROLE FUNGICIDES | SYNGENTA PARTICIPATIONS AG (SE) | 2017-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170000133-A1 | BENZOXABOROLE FUNGICIDES | CYP4X1, BROX, CYP1B1 | HTR4 4460/4885MAPT 2010/4885SMYD2 4770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.